Introducing the New Apraglutide ELISA Kit

We are excited to announce the newest addition to our expanding catalog — the Apraglutide ELISA Kit S- 1565, developed for precise and reliable quantification of Apraglutide in biological samples.

Whether you’re focused on peptide therapeutics, gastrointestinal research, or pharmacokinetic studies, this assay is designed to deliver the consistency and performance your lab needs.

Key Features:

✅High sensitivity and specificity for Apraglutide

✅Flexible use – Compatible with mouse, rat, human samples, and others

✅Robust reproducibility and linearity across runs

✅Optimized, ready-to-use reagent

 

Why it Matters:

Apraglutide is a novel, long-acting GLP-2 analogue under development for conditions like short bowel syndrome and other gastrointestinal disorders. Precise measurement of Apraglutide in biological samples is critical to:

• Pharmacokinetics & dosing – track absorption, distribution, metabolism, and elimination.
• Efficacy studies – correlate circulating Apraglutide levels with clinical outcomes such as improved nutrient absorption and gut function.
• Safety monitoring – ensure controlled exposure in preclinical and clinical studies.
• Translational research – compare results across species (mouse, rat, human, etc.) for smoother progression from bench to bedside.

Be among the first to integrate this essential tool into your research pipeline and contact us at info@bma.ch

We help you keep your research moving forward!

Your BMA team